A detailed history of Dodge & Cox transactions in Novartis Ag stock. As of the latest transaction made, Dodge & Cox holds 12,221,876 shares of NVS stock, worth $1.19 Billion. This represents 0.85% of its overall portfolio holdings.

Number of Shares
12,221,876
Previous 12,236,526 0.12%
Holding current value
$1.19 Billion
Previous $1.3 Billion 7.91%
% of portfolio
0.85%
Previous 0.82%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$106.13 - $120.89 $1.55 Million - $1.77 Million
-14,650 Reduced 0.12%
12,221,876 $1.41 Billion
Q2 2024

Aug 13, 2024

SELL
$92.57 - $107.37 $10.9 Million - $12.6 Million
-117,459 Reduced 0.95%
12,236,526 $1.3 Billion
Q1 2024

May 14, 2024

SELL
$95.27 - $108.47 $77.3 Million - $88 Million
-811,553 Reduced 6.16%
12,353,985 $1.2 Billion
Q4 2023

Feb 15, 2024

SELL
$92.27 - $101.54 $286 Million - $315 Million
-3,098,683 Reduced 19.05%
13,165,538 $1.33 Billion
Q3 2023

Nov 14, 2023

SELL
$94.73 - $105.13 $13.5 Million - $15 Million
-142,892 Reduced 0.87%
16,264,221 $1.66 Billion
Q2 2023

Aug 14, 2023

SELL
$92.52 - $104.91 $361 Million - $410 Million
-3,905,567 Reduced 19.23%
16,407,113 $1.66 Billion
Q1 2023

May 12, 2023

SELL
$80.03 - $92.81 $35.1 Million - $40.7 Million
-438,692 Reduced 2.11%
20,312,680 $1.87 Billion
Q4 2022

Feb 14, 2023

SELL
$75.55 - $92.52 $22.5 Million - $27.5 Million
-297,285 Reduced 1.41%
20,751,372 $1.88 Billion
Q3 2022

Nov 10, 2022

SELL
$74.61 - $87.26 $112 Million - $131 Million
-1,504,112 Reduced 6.67%
21,048,657 $1.6 Billion
Q2 2022

Aug 12, 2022

SELL
$80.52 - $93.75 $426 Million - $496 Million
-5,291,440 Reduced 19.0%
22,552,769 $1.91 Billion
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $32.5 Million - $36.7 Million
-405,331 Reduced 1.43%
27,844,209 $2.44 Billion
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $81 Million - $89.6 Million
-1,016,360 Reduced 3.47%
28,249,540 $2.47 Billion
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $394 Million - $458 Million
4,812,635 Added 19.68%
29,265,900 $2.39 Billion
Q2 2021

Aug 13, 2021

BUY
$85.24 - $94.15 $237 Million - $262 Million
2,783,028 Added 12.84%
24,453,265 $2.23 Billion
Q1 2021

May 14, 2021

BUY
$83.5 - $98.47 $4.55 Million - $5.36 Million
54,436 Added 0.25%
21,670,237 $1.85 Billion
Q4 2020

Feb 11, 2021

SELL
$78.07 - $94.43 $13.7 Million - $16.6 Million
-175,374 Reduced 0.8%
21,615,801 $2.04 Billion
Q3 2020

Nov 13, 2020

BUY
$82.14 - $91.0 $200 Million - $222 Million
2,437,388 Added 12.59%
21,791,175 $1.89 Billion
Q2 2020

Aug 13, 2020

SELL
$80.93 - $91.1 $290 Million - $327 Million
-3,587,653 Reduced 15.64%
19,353,787 $1.69 Billion
Q1 2020

May 14, 2020

SELL
$70.67 - $99.01 $160 Million - $224 Million
-2,264,141 Reduced 8.98%
22,941,440 $1.89 Billion
Q4 2019

Feb 13, 2020

SELL
$84.35 - $95.37 $132 Million - $149 Million
-1,563,295 Reduced 5.84%
25,205,581 $2.39 Billion
Q3 2019

Nov 13, 2019

SELL
$85.54 - $94.26 $227 Million - $250 Million
-2,655,693 Reduced 9.03%
26,768,876 $2.33 Billion
Q2 2019

Aug 13, 2019

SELL
$75.4 - $92.8 $522 Million - $642 Million
-6,920,026 Reduced 19.04%
29,424,569 $2.69 Billion
Q1 2019

May 14, 2019

SELL
$75.32 - $86.15 $34.2 Million - $39.1 Million
-454,023 Reduced 1.23%
36,344,595 $3.49 Billion
Q4 2018

Feb 14, 2019

SELL
$73.66 - $82.02 $557 Million - $620 Million
-7,562,769 Reduced 17.05%
36,798,618 $3.16 Billion
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $15.4 Million - $17.8 Million
229,525 Added 0.52%
44,361,387 $3.82 Billion
Q2 2018

Aug 14, 2018

SELL
$64.91 - $73.36 $10.9 Million - $12.3 Million
-168,300 Reduced 0.38%
44,131,862 $3.33 Billion
Q1 2018

May 14, 2018

SELL
$70.39 - $84.15 $19.7 Million - $23.5 Million
-279,225 Reduced 0.63%
44,300,162 $3.58 Billion
Q4 2017

Feb 14, 2018

SELL
$72.33 - $77.64 $4.67 Million - $5.01 Million
-64,538 Reduced 0.14%
44,579,387 $3.74 Billion
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $3.31 Billion - $3.45 Billion
44,643,925
44,643,925 $3.83 Billion

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $210B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Dodge & Cox Portfolio

Follow Dodge & Cox and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dodge & Cox, based on Form 13F filings with the SEC.

News

Stay updated on Dodge & Cox with notifications on news.